However, individual responses may differ, and lifestyle factors, such as diet and exercise, can influence weight loss outcomes
Retatrutide is delivered as a once-weekly subcutaneous injection and is being evaluated across multiple obesity-related conditions in Eli Lillys TRIUMPH Phase 3 clinical trial program, which is the largest registrational trial program ever launched for an anti-obesity medication
When used as part of a comprehensive care plan, it may help support: Compounded semaglutide is typically administered as a once-weekly injection under provider guidance
Paul Antoine Have you tried any natural methods to boost your GLP-1 levels or used nutrient-dense, high-satiety foods as an adjunct to GLP-1 agonists
Both medications contain the same active ingredient, semaglutide
Copyright 2023, 2026, Eli Lilly and Company